Domov › Prekomerna telesna teža › Ohio › Cincinnati

Klinične študije za Prekomerna telesna teža v Cincinnati, OH

14 študij za Prekomerna telesna teža išče udeležence na lokacijah v Cincinnati in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2

CTI Clinical Research Center /ID# 282043, Cincinnati

Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3

Midwest Eye Center, Cincinnati
Velocity Clinical Research, Mt. Auburn, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3

CTI Clinical Research Center, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Vključevanje udeležencevFaza 3

CTI Clinical Research Center, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3

Velocity Clinical Research - Auburn, Cincinnati

Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2

CTI Clinical Research Center, Cincinnati

Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3

AURORA-1 Clinical Site, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3

AURORA-2 Clinical Site, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3

CTI Clinical Research Center, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3

CTI Clinical Research Center, Cincinnati

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2

CTI Clinical Research Center, Cincinnati

Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3

Clinical Trial Investigator Clinical Research Center, Cincinnati
Velocity Clinical Research - Cincinnati, Cincinnati

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3

Velocity Clinical Research - Cincinnati, Cincinnati
Velocity Clinical Research - Springdale, Cincinnati

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

Effects of Exercise on Lipids and Endothelial Function in Youth

Vključevanje udeležencev

Cincinnati Children's Hospital Medical Center, Cincinnati

Starost 10–20 · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT07409064

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v Cincinnati

Vir: ClinicalTrials.gov, podatki pridobljeni 4. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.